All of the following statements about nesiritide are true EXCEPT:
**Question:** All of the following statements about nesiritide are true EXCEPT:
A. Nesiritide is a synthetic form of human B-type natriuretic peptide
B. Nesiritide is a potent vasodilator
C. Nesiritide increases renal blood flow and glomerular filtration rate
D. Nesiritide is a direct renin inhibitor
**Correct Answer:** **D. Nesiritide is a direct renin inhibitor:**
**Core Concept:** Nesiritide is a synthetic analogue of human B-type natriuretic peptide (BNP), which is released by the heart in response to increased intra-cardiac pressure and volume overload. BNP and its active peptide NT-proBNP are potent vasodilators and natriuretic hormones that help regulate fluid and electrolyte balance in the body.
**Why Nesiritide is NOT a direct renin inhibitor:**
Direct renin inhibition refers to the action of drugs that directly block the renin enzyme, thereby suppressing the renin-angiotensin-aldosterone system (RAAS) cascade. In contrast, nesiritide is a natriuretic hormone that works by binding to the BNP receptor, NPR-B, and activating guanylyl cyclase to increase cyclic GMP production. This leads to vasodilation, natriuresis, and diuresis. It does not directly inhibit renin, which is the primary mechanism of action of a direct renin inhibitor.
**Why the Other Options Are Correct:**
A. Nesiritide is a synthetic form of human B-type natriuretic peptide (BNP), which is released in response to cardiac stress. It shares the same receptor, NPR-B, and exerts its effects via cyclic GMP, as mentioned above.
B. Nesiritide is a potent vasodilator, which is a crucial aspect of its therapeutic action in treating congestive heart failure (CHF) and acute heart failure (AHF).
C. Nesiritide increases renal blood flow and glomerular filtration rate, which contributes to its natriuretic and diuretic effects, helping to reduce congestion in patients with AHF.
**Why Nesiritide is NOT a direct renin inhibitor:**
Nesiritide is a synthetic analogue of BNP, which works through NPR-B activation to increase cyclic GMP production. It does not directly inhibit renin, as a direct renin inhibitor would. In contrast, renin inhibitors would directly target the renin enzyme in the RAAS pathway, thereby suppressing the pathway upstream of BNP and its effects on cyclic GMP.